AMSTERDAM (AP) _ UniQure NV (QURE) on Monday reported a loss of $36.5 million in its third quarter.

The Amsterdam-based company said it had a loss of 79 cents per share.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1 per share.

The human gene therapy company posted revenue of $2 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $3.7 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News